Gene · 7045
Papers3,774
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,774
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unilateral lattice corneal dystrophy with c.1501C>A (p.P501T) and c.1733T>C (p.L578P) variants in the transforming growth factor-beta induced gene: a case report. | Ophthalmic Genet | 2025 | 39618086 | PubTator, text mining | PubMed |
| Localized Hydrogel Microspheres for Osteoarthritis Treatment: Recruitment and Differentiation of Stem Cells. | Adv Healthc Mater | 2025 | 39610189 | PubTator, text mining | PubMed |
| EIF3B affects the invasion and metastasis of hepatocellular carcinoma cells via the TGFBI/MAPK/ERK pathway. | Ann Hepatol | 2025 | 39276983 | PubTator, text mining | PubMed |
| Repeat Femtosecond-Assisted Anterior Lamellar Keratoplasty for Recurrence of TGF B I Dystrophy in Eyes After Previous FALK. | Cornea | 2025 | 39023340 | PubTator, text mining | PubMed |
| Matrix-associated extracellular vesicles modulate smooth muscle cell adhesion and directionality by presenting collagen VI. | bioRxiv | 2025 | 37645762 | PubTator, text mining | PubMed |
| Molecular mechanism detection of stage I to stage II transition of esophageal squamous cell carcinoma: a system biology approach. | Gastroenterol Hepatol Bed Bench | 2024 | 40406432 | PubTator, text mining | PubMed |
Unveiling a TGFBI Variant in the Retinal Capillary Hemangioblastoma, Type II Granular Corneal Dystrophy, and Von Hippel-Lindau Families: Unlocking Potential for Early Intervention and Targeted Therapy. | J Curr Ophthalmol | 2024 | 40012800 | PubTator, text mining | PubMed |
| Molecular genetic analysis of R124H TGFBIp in one family Avellino corneal dystrophy. | Mol Vis | 2024 | 39959167 | PubTator, text mining | PubMed |
| Enter the Matrix: Fibroblast-immune cell interactions shape extracellular matrix deposition in health and disease. | F1000Res | 2024 | 39886650 | PubTator, text mining | PubMed |
| Adipose Tissue as a Major Launch Spot for Circulating Extracellular Vesicle-Carried MicroRNAs Coordinating Tissue and Systemic Metabolism. | Int J Mol Sci | 2024 | 39769251 | PubTator, text mining | PubMed |
| In Silico and In Vitro Study of mRNA Biomarkers for Glioblastoma Multiforme Resistance to Temozolomide (TMZ): The Association with Stemness. | Asian Pac J Cancer Prev | 2024 | 39733437 | PubTator, text mining | PubMed |
| Identification and Validation of Serum Biomarkers to Improve Colorectal Cancer Diagnosis. | Cancer Med | 2024 | 39628390 | PubTator, text mining | PubMed |
| Meta-analysis of proteomics data from osteoblasts, bone, and blood: Insights into druggable targets, active factors, and potential biomarkers for bone biomaterial design. | J Tissue Eng | 2024 | 39620099 | PubTator, text mining | PubMed |
| Urinary DNA-methylation and protein biomarkers identify urothelial carcinoma among other genitourinary diseases and cancer-free individuals. | J Transl Med | 2024 | 39587670 | PubTator, text mining | PubMed |
| MiR-21-5p Promotes Osteogenic Differentiation and Calcification of Valvular Interstitial Cells by Targeting TGFBI in Calcific Aortic Valve Disease. | Iran J Public Health | 2024 | 39544858 | PubTator, text mining | PubMed |
| STAVER: a standardized benchmark dataset-based algorithm for effective variation reduction in large-scale DIA-MS data. | Brief Bioinform | 2024 | 39504480 | PubTator, text mining | PubMed |
| Are we better together? Addressing a combined treatment of pitavastatin and temozolomide for brain cancer. | Eur J Pharmacol | 2024 | 39491742 | PubTator, text mining | PubMed |
| Integrated analysis of bulk and single-cell RNA sequencing reveals the impact of nicotinamide and tryptophan metabolism on glioma prognosis and immunotherapy sensitivity. | BMC Neurol | 2024 | 39468708 | PubTator, text mining | PubMed |
| Free tools for crystallographic symmetry handling and visualization. | J Appl Crystallogr | 2024 | 39387077 | PubTator, text mining | PubMed |
| Comprehensive analysis of bulk, single-cell RNA sequencing, and spatial transcriptomics revealed IER3 for predicting malignant progression and immunotherapy efficacy in glioma. | Cancer Cell Int | 2024 | 39354533 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7045/papers?page=9